Analyst Reco. United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
275 ^USD	-0.51%		-0.05%	+25.06%

Jun. 03	Liquidia's Yutrepia Launch Cleared as Court Denies Injunction	MT
May. 16	United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Liquidia's Yutrepia Launch Cleared as Court Denies Injunction	Jun. 03	MT
United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing	May. 16	MT
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing	May. 14	MT
United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing	May. 10	MT
United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing	May. 08	MT
United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing	May. 07	MT
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing	May. 06	MT
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing	May. 06	MT
United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing	May. 03	MT
UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating	May. 02	MT
Oppenheimer Adjusts United Therapeutics Price Target to $400 From $375, Maintains Outperform Rating	May. 02	MT
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing	Apr. 19	MT
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing	Apr. 17	MT
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing	Apr. 15	MT
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing	Apr. 11	MT
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing	Apr. 09	MT
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing	Apr. 05	MT
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing	Apr. 04	MT
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing	Mar. 25	MT
United Therapeutics Insider Sold Shares Worth $1,418,726, According to a Recent SEC Filing	Mar. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. United Therapeutics Corporation

Equities

UTHR

US91307C1027

Analyst Reco.

Filters